Aosa Pharma
奥萨制药
MedTech, BioTech & PharmaShenzhen · South (Guangdong · Hong Kong · Hainan)
Business focus
MedTech, BioTech & Pharma
Description
Founded 2007 in Nanshan, Shenzhen; develops diagnostic and therapeutic products for cardio-cerebrovascular disease. Its enalapril-folic acid tablet (a Chinese Category 1 new drug) paired with an MTHFR gene diagnostic kit is described as the world's first combined product for individualized diagnosis and treatment of common cardio-cerebrovascular conditions. Operates GMP-compliant manufacturing (solid dosage forms, in vitro diagnostics, medical devices) and holds national high-tech enterprise status.